Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window.30-12-2019
30-12-2019
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 25, 2019 for Ashu Farms LLP25-12-2019
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation Regarding Issue Of Duplicate Share Certificate.30-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Related Party Transaction For The Half Year Ended 30Th Sept 2019.
Related Party Transaction for the half year ended 30th Sept 2019.26-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript on Conference Call held on 04th Nov 2019.07-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment & Infrastructure Ltd06-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2019 for Ashu Farms LLP04-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Presenatation On Unaudited Financial Results As On 30Th Sept 2019
Presenatation on Unaudited Financial Results as on 30th Sept 201902-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th Sept 2019
Unaudited Financial Results for the quarter and half year ended 30th Sept 201902-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Outcome of Board Meeting
Outcome of Board Meeting held on 02nd November 2019 and Unaudited Financial Results for the quarter and half year ended 30th September 2019.02-11-2019